What Daesang Welllife does

Daesang Welllife is a South Korean total healthcare nutrition company and a subsidiary of Daesang Group, operating the NUCARE brand family that has held the No. 1 position in South Korea's medical nutrition food market by revenue for ten consecutive years (2014–2023). The company serves patients with medical nutritional needs (cancer, diabetes, hypertension, IBD, diabetic kidney disease, dysphagia), diabetics and pre-diabetics, children, teens, health-conscious adults, and athletes through seven NUCARE sub-brands (Balanced Nutrition, Specialized Nutrition, Glucose Plan, MYKIDS, HIGH MENTOR, ALL PROTEIN, SPORTSIX), plus the ArPOTEN energy supplement brand, the gutsys women's gut-health brand, and a Health Supplements category built on proprietary functional ingredients.

The company's core technology rests on over 50 years of food research, including Korea's first chlorella cultivation method (1993 patent), Korea's only MFDS-recognized L-arginine fermentation ingredient (covering both blood circulation and, as of 2025, fatigue improvement), and a patented plant-based DHA oil produced via microalgae cultivation (1992). Manufacturing is concentrated at two Cheonan plants (Plant 1 and Plant 2) holding Smart HACCP, GMP, FSSC 22000, ISO 9001/14001/45001, HALAL, and KOSHER certifications. The DiabetesPro mobile app adds a digital layer, providing AI-driven dietary missions, automated blood sugar log analysis, and a points-based reward system integrated with NUCARE Glucose Plan.

Daesang Welllife monetizes predominantly through one-time sales of consumer nutrition products, distributed across hospital and pharmacy shop-in-shop networks (approximately 5,000 medical institutions), direct-to-consumer e-commerce (Wellife Mall, Naver Smart Store, Coupang), physical retail (department stores, Costco), and a B2B mall. International export distribution extends to 10+ countries (Vietnam, Japan, China, Taiwan, Malaysia, Mongolia, USA, Saudi Arabia, UAE, Singapore). The DiabetesPro app represents a recurring/engagement revenue model tied to NUCARE Glucose Plan consumption. Recent strategic actions include the October 2024 acquisition of a 90% stake in F&D Net for 53 billion KRW (expanding the hospital/pharmacy channel and adding probiotic/prenatal vitamin brands) and the August 2023 acquisition of RexSoft, the company's first subsidiary, providing in-house data science capabilities.

Name

Daesang Welllife

Legal name

Daesang Welllife Co., Ltd.

Website

https://daesangwellife.com

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Daesang Welllife is a South Korean healthcare nutrition company operating the NUCARE brand family, providing research-based medical, diabetes, children's, sports, and functional supplement products across hospital, pharmacy, retail, and e-commerce channels in 10+ countries.

Ownership category

akta.pro rank

Product category

Medical Nutrition Foods

NAICS

Food (Health) Supplement Retailers (456191), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industries

Weight Management & Metabolic Supplements (CRADAGAG), Children’s Vitamins & Supplements (CRADAGAJ), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Medical nutrition products
• Functional food manufacturing
• Clinical nutrition solutions
• Health supplement products
• Diabetes nutrition products

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. NUCARE Balanced and Specialized Nutrition Products: Medical nutrition products including balanced nutrition formulas, specialized FSMP products for patients (cancer, hypertension, diabetes, IBD), and tube-feeding (RTH) products. Sold primarily through hospital and pharmacy shop-in-shop channels and e-commerce platforms. Revenue recognized at point of sale with recurring purchase patterns driven by ongoing patient needs.
2. NUCARE Lifestyle Nutrition Products: Consumer-facing products including NUCARE Glucose Plan (diabetes nutrition), NUCARE MYKIDS (children's nutrition), NUCARE HIGH MENTOR (teen nutrition), NUCARE ALL PROTEIN (protein beverages), and NUCARE SPORTSIX (sports nutrition). Sold through Wellife Mall, Naver Smart Store, department stores, Costco, and other retail channels.
3. Health Supplements: Health functional foods including ArPOTEN (L-arginine energy supplements), gutsys (gut health), chlorella products, and general health supplements. Sold through multiple retail and e-commerce channels domestically and through exports internationally.
4. DiabetesPro App and Digital Platform: Mobile health application for blood sugar management integrated with NUCARE Glucose Plan products, offering rewards, AI-driven dietary missions, and health tracking to drive product engagement and brand loyalty.

Pricing tiers

Go-to-market motion2 records

Distribution channels8 records

Marketing channels7 records

Core offering

Daesang Welllife manufactures and sells personalized nutrition products under its flagship NUCARE brand family for medical patients (FSMP), diabetics, children, teens, adults, and athletes. The company also markets health supplements including chlorella and L-Arginine-based products (ArPOTEN, gutsys), and operates the DiabetesPro mobile app for AI-powered blood sugar management.

Product overview

Daesang Welllife is a Total Healthcare Solution company offering personalized nutrition solutions tailored to every stage of life and lifestyle. The company's product portfolio centers around the NUCARE brand family, which includes seven sub-brands: NUCARE Balanced Nutrition (general patient nutrition), NUCARE Specialized Nutrition (FSMP products for cancer, hypertension, IBD, diabetic kidney disease patients), NUCARE Glucose Plan (diabetes nutrition - No.1 in Korea), NUCARE MYKIDS (children's nutrition), NUCARE HIGH MENTOR (teen nutrition), NUCARE ALL PROTEIN (adult protein nutrition), and NUCARE SPORTSIX (sports nutrition). Beyond NUCARE, the company offers ArPOTEN (energy/L-Arginine supplements), gutsys (women's gut health), and general Health Supplements including chlorella and plant-based DHA. The portfolio is supported by the DiabetesPro APP with AI-powered dietary recommendations. Recent acquisitions include F&D Net (probiotic/maternal health) and RexSoft (data science software).

Differentiator

Problem solved

Functional benefit

Brands

• NUCARE: Leading balanced nutrition brand offering products for various patients, including specialized nutrition, glucose management, children's nutrition, teen nutrition, protein nutrition, and sports nutrition.
• NUCARE Glucose Plan
• NUCARE MYKIDS
• NUCARE HIGH MENTOR
• NUCARE ALL PROTEIN
• NUCARE SPORTSIX
• NUCARE Specialized Nutrition
• ArPOTEN
• gutsys
• Health Supplements
• DiabetesPro

Products and services

• NUCARE Balanced Nutrition

Quantifiable outcome

• NUCARE ranked No.1 in South Korean medical nutrition food sales for 10 consecutive years (2014-2023) by revenue (Ministry of Food and Drug Safety)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

13 partnerships are on record, tiered core, minor and major.

• Korean Society of Dysphagia (대한연하장애학회)coreStrategic or Co-development Partner · 15 April 2026MOU signed to improve awareness and management of swallowing disorders (dysphagia). Joint campaign will distribute educational materials to approximately 5,000 medical institutions, provide training for caregivers on IDDSI-compliant thickener use, and distribute dysphagia screening questionnaires to long-term care facilities.
• WBFF (World Beauty Fitness & Fashion)minorGTM or Marketing Partner · 1 January 2025Daesang Wellife Chlorella designated as Official Health Supplement by WBFF in 2016, supporting international sports and wellness brand association.
• F&D Net (acquired entity)coreStrategic or Co-development Partner · 15 October 2024Daesang Welllife acquired a 90% stake in F&D Net for 53 billion KRW from UCK Partners and founding shareholders. F&D Net is known for probiotic product 'Lactipdo' and prenatal vitamins, operates through hospital and pharmacy shop-in-shop channels in South Korea, with revenue of approximately 589 billion won. The acquisition strengthens Daesang Welllife's position in maternal and infant health functional food market and enables expansion into overseas markets including Vietnam.
• RMHC Korea (Ronald McDonald House Charities Korea)minorOthers · 1 January 2024Partnership with RMHC Korea to support long-term young patients and their families staying at the RMHC Korea Yangsan House within Yangsan Pusan National University Children's Hospital. Various NUCARE products are supplied for meal replacements for caregivers and nutritious snacks for children.
• Hanwha EaglesminorGTM or Marketing Partner · 1 January 2024Sponsorship agreement signed with Hanwha Eagles professional baseball team, supporting sports nutrition and athlete wellness while building brand visibility in sports.
• RexSoft (acquired subsidiary)coreTechnology or Integration · 8 August 2023Daesang Welllife acquired data science company RexSoft as its first subsidiary in August 2023. RexSoft provides Rex Pro, an Excel-based data processing tool enabling easy data analysis for users without statistics or programming backgrounds. This acquisition represents Daesang Welllife's entry into digital and data science capabilities.
• National Cancer Center (국립암센터)coreStrategic or Co-development Partner · 1 January 2023Ongoing 'Care Bridge' (케어브릿지) CSR program partnership providing nutritional support to 90 low-income cancer patients with approximately 2 months of NUCARE nutrition packages. Entered its second consecutive year in 2025.
• Sinopharm GroupmajorStrategic or Co-development Partner · 1 January 2022Daesang Welllife signed an MOU with Sinopharm Group for strategic cooperation, representing a key partnership for expanding into the Chinese market with customized nutrition solutions.
• Korea Association for Children with Leukemia and Cancer (KACLC)minorOthers · 1 January 2021Donated NUCARE MYKIDS to children battling leukemia and pediatric cancer, offering comfort and nutritional support during grueling chemotherapy treatments.
• Seungil Hope FoundationminorOthers · 1 January 2020Partnership with Korea's only nonprofit foundation dedicated to ALS patients. Daesang Welllife provides NUCARE products for ALS patients and supports the 'Miracle 365 X Ice Bucket Challenge Run' campaign. During the 2021-2022 KBL All-Star Game, a donation was made to the ALS care center construction fund.
• Korean Society of Clinical NutritioncoreStrategic or Co-development Partner · 1 January 2019Co-developed Korea's first FSMP product for diabetic kidney disease (NUCARE Diabetes Plan Kidney) with the Korean Society of Clinical Nutrition, reflecting deep clinical and academic partnership.
• Gachon University Gil Medical Center, Seoul St. Mary's Hospital, and 15+ other Korean medical institutionscoreStrategic or Co-development PartnerExtensive clinical research network involving Gachon University Gil Medical Center, Seoul St. Mary's Hospital (Catholic University), St. Vincent's Hospital, Gangnam Severance Hospital, Kyung Hee University Hospital, National Cancer Center, Dankook University College of Dentistry, Samsung Medical Center, and others for clinical studies supporting product development and efficacy validation.
• Happy AllianceminorOthersMember of Happy Alliance, a collaborative safety net formed by businesses, local governments, and citizens. Daesang Welllife supports the 'Together Strong MYKIDS' project providing NUCARE MYKIDS nutritional snacks to children at risk of missing meals, expanding from Cheonan (2023) to Dongdaemun-gu (2024) and Seongdong-gu (2025) in Seoul.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Abbott Nutrition: Global leader in medical nutrition (Ensure, Glucerna, Similac) with deep hospital relationships and diabetes-specific lines analogous to NUCARE Glucose Plan. Comparable as a broad incumbent whose diabetes and adult nutrition portfolio directly overlaps Daesang Welllife's flagship franchises.
• Nestlé Health Science: Global medical nutrition leader (Peptamen, Resource, Compleat) serving hospitals and consumers worldwide. Directly comparable as a multinational incumbent in the FSMP and clinical nutrition categories where Daesang Welllife's NUCARE Specialized Nutrition and Glucose Plan compete for hospital formularies and consumer mindshare.
• Meiji Holdings: Japanese food and nutrition conglomerate with functional milk, sports nutrition (Savas), and supplement offerings. Comparable because of overlap with NUCARE SPORTSIX in sports nutrition and NUCARE MYKIDS/HIGH MENTOR in children's/teen nutrition, especially for cross-border Asia distribution.
• Yakult Honsha: Japanese-origin probiotic functional food giant with global distribution and clinical research. Comparable to F&D Net's probiotic franchise (Lactipdo) and Daesang Welllife's gutsys women's gut health brand, both targeting functional/clinical probiotic positioning.
• CJ CheilJedang: Major Korean food conglomerate with health-functional food, meal replacement, and supplement subsidiaries. Comparable as a diversified Korean peer with overlapping health-food and FSMP-adjacent product portfolios and similar hospital/retail distribution dynamics.
• Danone Nutricia: Major global medical nutrition player (Nutrison, Fortisip) with strong clinical presence. Comparable because its FSMP and adult disease-focused nutrition offerings compete in the same hospital and patient-nutrition space as NUCARE Specialized Nutrition, particularly across Asian markets Daesang Welllife is entering.

Regional players

• Morinaga Milk Industry: Japanese dairy and nutrition company with infant, adult, and medical nutrition lines. Comparable as a regional incumbent with Japan-Asia medical nutrition presence similar to NUCARE's specialty nutrition positioning across Asian export markets.
• Maeil Dairies: Leading Korean dairy and functional food company with consumer health and children's nutrition SKUs. Comparable as a Korean domestic peer competing on retail shelves and in the same regulatory environment, with overlapping children's and adult nutrition categories.
• Korea Ginseng Corporation (KGC): South Korean state-affiliated ginseng/health supplement leader. Comparable as a domestic functional supplement peer sharing regulatory channels (MFDS functional ingredient approvals) and competing for health-functional food positioning in Korea.

Others

• Amorepacific: Korean beauty/health conglomerate with internal beauty and wellness nutrition lines. Comparable as a Korean conglomerate peer leveraging brand power and e-commerce channels for health adjacencies that could encroach on Daesang Welllife's gut-health and supplement categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Nucare.official
• Instagraminstagram.com/nucare.official

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Daesang Welllife